focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (DD) - Cello Health plc

10 Aug 2020 14:30

RNS Number : 6858V
Cello Health PLC
10 August 2020
 

FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Mark Scott

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Cello Health plc

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Person acting in concert with the offeree

(e) Date dealing undertaken:

7 August 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

10p ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,351,225

2.12

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

 

2,351,225

 

2.12

 

Nil

 

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

10p ordinary shares

PSP 2010 call options

Exercising

701,250

10p

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

10 August 2020

Contact name:

Mark Scott

Telephone number:

+44 (0)20 7812 8468

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DCCBXGDICBBDGGG
Date   Source Headline
17th Mar 20097:00 amRNSFinal Results
26th Feb 20098:00 amRNSNotice of Results
19th Jan 20097:00 amRNSYear end trading update
18th Dec 200812:38 pmRNSKevin Steeds
4th Dec 20087:00 amRNSDirector/PDMR Shareholding
30th Oct 20081:33 pmRNSChange of Adviser Name
16th Sep 20087:00 amRNSInterim Results
2nd Sep 20082:00 pmRNSInterim Board role change
18th Aug 20084:12 pmRNSNotice of Results
18th Aug 20081:13 pmRNSHolding(s) in Company
13th Aug 20082:16 pmRNSHolding(s) in Company
6th Aug 20082:56 pmRNSHolding(s) in Company
4th Jul 20087:00 amRNSHalf year trading update
24th Jun 200810:44 amRNSDirector/PDMR Shareholding
12th Jun 20081:22 pmRNSDirector/PDMR Shareholding
20th May 20081:25 pmRNSAGM Statement
23rd Apr 200812:59 pmRNSAnnual Report & AGM
17th Apr 20087:00 amRNSAdditional Listing / TVR
28th Mar 20086:11 pmRNSAdditional listing / TVR
25th Mar 20084:04 pmRNSDirector/PDMR Shareholding
19th Mar 20088:35 amRNSDirector/PDMR Shareholding
18th Mar 200810:40 amRNSPerformance Share Option Plan
18th Mar 20087:01 amRNSFinal Results
26th Feb 20087:01 amRNSTotal Voting Rights
13th Feb 200811:03 amRNSNotice of Results
17th Jan 200810:53 amRNSTransaction in Own Shares
16th Jan 20083:03 pmRNSDirector/PDMR Shareholding
16th Jan 20082:19 pmRNSTransaction in Own Shares
16th Jan 200810:54 amRNSTransaction in Own Shares
15th Jan 20087:00 amRNSTrading Statement
3rd Jan 20084:56 pmRNSNotification of Interests
21st Dec 20078:05 amRNSChange of Adviser
14th Dec 200711:10 amRNSDirector/PDMR Shareholding
30th Nov 20073:29 pmRNSTotal Voting Rights
24th Oct 20071:30 pmRNSDirector/PDMR Shareholding
24th Oct 20077:00 amRNSPerformance Share Option Plan
23rd Oct 20077:01 amRNSAcquisition
2nd Oct 20079:59 amRNSTransactions in own shares
26th Sep 200711:35 amRNSAdditional Listing
17th Sep 20077:01 amRNSAcquisition
11th Sep 20077:01 amRNSInterim Results
31st Aug 20075:08 pmRNSTVR Update
30th Aug 20079:15 amRNSAdoption of IFRS
20th Aug 20072:53 pmRNSNotice of Results
13th Aug 20074:40 pmRNSRule 26
30th Jul 20071:55 pmRNSAdditional Listing
20th Jul 200710:00 amRNSHolding(s) in Company
12th Jul 20077:00 amRNSTrading Statement
9th Jul 20072:06 pmRNSTotal Voting Rights
6th Jul 20077:01 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.